GreatNorthCollective/greatnorth-canada-federal-laws-text huggingface dataset:
Hazardous Products Regulations — Hazardous Products Regulations
adverse effects on the development of the embryo, fetus or offspring means any adverse effects of a mixture or substance on the embryo, fetus or offspring, resulting from exposure of either parent to the mixture or substance prior to conception or exposure of the developing embryo or fetus to the mixture or substance during prenatal development, or of the offspring during postnatal development to the time of sexual maturation, that is manifested at any point in the development of the embryo or fetus, or that is manifested at any point in the lifespan of the offspring, and that includes the loss of the embryo or fetus, death of the developing offspring, structural abnormality, altered growth and functional deficiency. This definition excludes the induction of genetically based inheritable effects in the offspring. ( effets néfastes sur le développement de l’embryon, du foetus ou de la progéniture )
Hazardous Products Regulations — (a)
effects on or via lactation means (a) any effect of a mixture or substance that interferes with lactation; or (b) the presence of the mixture or substance, or its metabolites, in the maternal milk in amounts for which there is evidence that supports the conclusion, based on established scientific principles, that the health of the breast-fed child or suckling animal is liable to be threatened. ( effets sur ou via l’allaitement )
Hazardous Products Regulations — (a)
reproductive toxicity refers to any of the following effects occurring after exposure to a mixture or substance: (a) adverse effects on sexual function and fertility; (b) adverse effects on the development of the embryo, fetus or offspring; or (c) effects on or via lactation. ( toxicité pour la reproduction )
Hazardous Products Regulations — Hazardous Products Regulations
toxic to reproduction means, in relation to a mixture or substance, liable to lead to reproductive toxicity. ( toxique pour la reproduction )
Hazardous Products Regulations — 8.7.1
Categories or subcategories — Categories 1A, 1B and 2 8.7.1 (1) A substance that is toxic to reproduction is classified in a category or subcategory of this hazard class in accordance with the following table: TABLE Column 1 Column 2 Column 3 Item Category Subcategory Criteria 1 Reproductive Toxicity — Category 1 Reproductive Toxicity — Category 1A A substance in respect of which human data demonstrate that exposure to the substance leads to adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring 2 Reproductive Toxicity — Category 1 Reproductive Toxicity — Category 1B A substance in respect of which animal data demonstrate that exposure of the animal to the substance leads to the following: (a) adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in the absence of other toxic effects; or (b) adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in the presence of other toxic effects, provided that such adverse effects are not considered to be a secondary non-specific consequence of the other toxic effects 3 Reproductive Toxicity — Category 2 A substance in respect of which human or animal data support a positive association between exposure to the substance and adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, but do not support a conclusion, based on established scientific principles, that exposure to the substance leads to such effects, provided that such effects are not considered to be a secondary non-specific consequence of other toxic effects Category — effects on or via lactation (2) A substance that is toxic to reproduction is classified in the category of this hazard class in accordance with the following table: TABLE Column 1 Column 2 Item Category Criteria 1 Reproductive Toxicity — Effects on or via Lactation A substance that, according to human or animal data, has effects on or via lactation SOR/2022-272, s. 53
Hazardous Products Regulations — (a)
A substance in respect of which animal data demonstrate that exposure of the animal to the substance leads to the following: (a) adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in the absence of other toxic effects; or (b) adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in the presence of other toxic effects, provided that such adverse effects are not considered to be a secondary non-specific consequence of the other toxic effects
Hazardous Products Regulations — (a)
(a) adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in the absence of other toxic effects; or
Hazardous Products Regulations — (b)
(b) adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in the presence of other toxic effects, provided that such adverse effects are not considered to be a secondary non-specific consequence of the other toxic effects
Hazardous Products Regulations — 8.7.2
Order of provisions 8.7.2 Subject to subsection 8.7.5(2), the classification of a mixture as a mixture that is toxic to reproduction in a category or subcategory of this hazard class must proceed in accordance with the order of sections 8.7.3 to 8.7.6.
Hazardous Products Regulations — 8.7.3
Ingredient classified in Category 1 or 1A 8.7.3 (1) A mixture is classified in the category “Reproductive Toxicity — Category 1” or the subcategory “Reproductive Toxicity — Category 1A” if it contains at least one ingredient at a concentration equal to or greater than the concentration limit of 0.1% that is classified in the subcategory “Reproductive Toxicity — Category 1A”, unless (a) there are data for the mixture as a whole that demonstrate conclusively, based on established scientific principles, that the mixture has adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in which case the mixture is classified as a mixture that is toxic to reproduction in accordance with subsection 8.7.1(1); or (b) the mixture as a whole has been subjected to a reproductive toxicity study that determines that the mixture does not have adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, and a scientifically validated method was used and the study was performed in accordance with generally accepted standards of good scientific practice at the time it was carried out. Ingredient classified in Category 1 or 1B (2) A mixture is classified in the category “Reproductive Toxicity — Category 1” or the subcategory “Reproductive Toxicity — Category 1B” if it contains at least one ingredient at a concentration equal to or greater than the concentration limit of 0.1% that is classified in the subcategory “Reproductive Toxicity — Category 1B”, and does not contain any ingredient at a concentration equal to or greater than the concentration limit of 0.1% that is classified in the subcategory “Reproductive Toxicity — Category 1A”, unless (a) there are data for the mixture as a whole that demonstrate conclusively, based on established scientific principles, that the mixture has adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in which case the mixture is classified as a mixture that is toxic to reproduction in accordance with subsection 8.7.1(1); or (b) the mixture as a whole has been subjected to a reproductive toxicity study that determines that the mixture does not have adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, and a scientifically validated method was used and the study was performed in accordance with generally accepted standards of good scientific practice at the time it was carried out. SOR/2022-272, s. 54
Hazardous Products Regulations — 8.7.4
Ingredient classified in Reproductive Toxicity — Category 2 8.7.4 A mixture is classified in the category “Reproductive Toxicity — Category 2” if it contains at least one ingredient at a concentration equal to or greater than the concentration limit of 0.1% that is classified in the category “Reproductive Toxicity — Category 2”, unless (a) there are data for the mixture as a whole that demonstrate conclusively, based on established scientific principles, that the mixture has adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, in which case the mixture is classified as a mixture that is toxic to reproduction in accordance with subsection 8.7.1(1); or (b) the mixture as a whole has been subjected to a reproductive toxicity study that determines that the mixture does not have adverse effects on sexual function and fertility or adverse effects on the development of the embryo, fetus or offspring, and a scientifically validated method was used and the study was performed in accordance with generally accepted standards of good scientific practice at the time it was carried out.
Hazardous Products Regulations — 8.7.5
Ingredient classified in Reproductive Toxicity — Effects on or via Lactation 8.7.5 (1) A mixture is classified in the category “Reproductive Toxicity — Effects on or via Lactation” if it contains at least one ingredient at a concentration equal to or greater than the concentration limit of 0.1% that is classified in the category “Reproductive Toxicity — Effects on or via Lactation”, unless (a) there are data for the mixture as a whole that demonstrate conclusively, based on established scientific principles, that the mixture has effects on or via lactation, in which case the mixture is classified as a mixture that is toxic to reproduction in accordance with subsection 8.7.1(2); or (b) the mixture as a whole has been subjected to a reproductive toxicity study that determines that the mixture does not have effects on or via lactation, and a scientifically validated method was used and the study was performed in accordance with generally accepted standards of good scientific practice at the time it was carried out. Classification in Category 1A, 1B or 2 and in Reproductive Toxicity — Effects on or via Lactation (2) Despite subsection 2.2(3), a mixture that has been classified in accordance with section 8.7.3 or 8.7.4 and meets the criteria of subsection (1) is also classified in the category “Reproductive Toxicity — Effects on or via Lactation”.
Hazardous Products Regulations — 8.7.6
Data available for use of bridging principles 8.7.6 If data are available to enable the characterization of the mixture as toxic to reproduction in accordance with the bridging principles referred to in subsections 2.3(3), (4) and (7), the mixture must be classified in accordance with those subsections, in the following categories: (a) “Reproductive Toxicity — Category 1”; (b) “Reproductive Toxicity — Category 2”; (c) “Reproductive Toxicity — Effects on or via Lactation”; (d) both “Reproductive Toxicity — Category 1” and “Reproductive Toxicity — Effects on or via Lactation”; or (e) both “Reproductive Toxicity — Category 2” and “Reproductive Toxicity — Effects on or via Lactation”.
Hazardous Products Regulations — 8.8
Definitions 8.8 The following definitions apply in this Subpart. narcotic effects means central nervous system depression that (a) in humans, may present as drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, vertigo, severe headache or nausea and may lead to reduced judgment, dizziness, irritability, fatigue, impaired memory function, deficits in perception or coordination, prolonged reaction time or sleepiness; and (b) in animals, may be observed as lethargy, lack of coordination righting reflex, narcosis or ataxia. ( effets narcotiques ) organ includes any biological system. ( organe ) respiratory tract irritation means localized redness, edema, pruritis or irritant effects in the respiratory tract that impair its function, whether or not accompanied by cough, pain, choking, breathing difficulties or other respiratory symptoms. ( irritation des voies respiratoires ) specific target organ toxicity arising from a single exposure means specific, non-lethal toxic effects on target organs that arise from a single exposure to a mixture or substance, including all health effects liable to impair function of the body or any of its parts, whether reversible or irreversible, immediate or delayed, but excludes effects resulting from health hazards addressed by Subparts 1 to 7 and 10 of this Part. ( toxicité pour certains organes cibles à la suite d’une exposition unique )
Hazardous Products Regulations — (a)
narcotic effects means central nervous system depression that (a) in humans, may present as drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, vertigo, severe headache or nausea and may lead to reduced judgment, dizziness, irritability, fatigue, impaired memory function, deficits in perception or coordination, prolonged reaction time or sleepiness; and (b) in animals, may be observed as lethargy, lack of coordination righting reflex, narcosis or ataxia. ( effets narcotiques )
Hazardous Products Regulations — Hazardous Products Regulations
organ includes any biological system. ( organe )
Hazardous Products Regulations — Hazardous Products Regulations
respiratory tract irritation means localized redness, edema, pruritis or irritant effects in the respiratory tract that impair its function, whether or not accompanied by cough, pain, choking, breathing difficulties or other respiratory symptoms. ( irritation des voies respiratoires )
Hazardous Products Regulations — Hazardous Products Regulations
specific target organ toxicity arising from a single exposure means specific, non-lethal toxic effects on target organs that arise from a single exposure to a mixture or substance, including all health effects liable to impair function of the body or any of its parts, whether reversible or irreversible, immediate or delayed, but excludes effects resulting from health hazards addressed by Subparts 1 to 7 and 10 of this Part. ( toxicité pour certains organes cibles à la suite d’une exposition unique )
Hazardous Products Regulations — 8.8.1
Two evaluations 8.8.1 (1) In order to establish the classification of a substance that causes specific target organ toxicity arising from a single exposure in one or more categories of this hazard class, the substance must be evaluated in accordance with all the criteria set out in column 2 of the following table, in relation to toxic effects on (a) the central nervous system and respiratory tract; and (b) other specific target organs. TABLE Column 1 Column 2 Item Category Criteria 1 Specific Target Organ Toxicity — Single Exposure — Category 1 A substance that (a) according to human data, causes specific target organ toxicity arising from a single exposure; or (b) according to animal data, causes specific target organ toxicity arising from a single exposure at low exposure concentrations, within the concentration value ranges set out for Category 1 in Table 3.8.1 of the GHS 2 Specific Target Organ Toxicity — Single Exposure — Category 2 A substance that, according to animal data, causes specific target organ toxicity arising from a single exposure at moderate exposure concentrations, within the concentration value ranges set out for Category 2 in Table 3.8.1 of the GHS 3 Specific Target Organ Toxicity — Single Exposure — Category 3 A substance in respect of which data demonstrate that a single exposure to the substance generates transient narcotic effects or transient respiratory tract irritation Classification (2) Following the evaluations referred to in subsection (1), the substance is classified in one or more categories of this hazard class, based on the results of the evaluations of its toxic effects as set out in columns 1 and 2 of the following table, in accordance with the corresponding category set out in column 3: TABLE Column 1 Column 2 Column 3 Item Number of the Table to Subsection (1) that is Associated with the Criteria in Column 2 of that Table that are Determined to Have Been Met as a Result of the Evaluation of the Following: Classification Item Toxic Effects on the Central Nervous System and Respiratory Tract Toxic Effects on Other Specific Target Organs Category of the “Specific Target Organ Toxicity — Single Exposure” Hazard Class 1 None Item 1 Category 1 2 Item 1 None Category 1 3 Item 1 Item 1 Category 1 4 None Item 2 Category 2 5 Item 2 None Category 2 6 Item 1 Item 2 Category 1 7 Item 2 Item 1 Category 1 8 Item 2 Item 2 Category 2 9 Item 3 None Category 3 10 Item 3 Item 1 Category 1 and Category 3 11 Item 3 Item 2 Category 2 and Category 3
Hazardous Products Regulations — (a)
A substance that (a) according to human data, causes specific target organ toxicity arising from a single exposure; or (b) according to animal data, causes specific target organ toxicity arising from a single exposure at low exposure concentrations, within the concentration value ranges set out for Category 1 in Table 3.8.1 of the GHS
Hazardous Products Regulations — (a)
(a) according to human data, causes specific target organ toxicity arising from a single exposure; or
Hazardous Products Regulations — (b)
(b) according to animal data, causes specific target organ toxicity arising from a single exposure at low exposure concentrations, within the concentration value ranges set out for Category 1 in Table 3.8.1 of the GHS
Hazardous Products Regulations — 8.8.2
Order of provisions 8.8.2 The classification of a mixture as a mixture that causes specific target organ toxicity arising from a single exposure in a category of this hazard class must proceed in accordance with the order of sections 8.8.3 to 8.8.5.
Hazardous Products Regulations — 8.8.3
Data available for mixture as a whole 8.8.3 If data of the types referred to in subparagraphs 2.1(a)(i) to (iv) are available for the mixture as a whole, the mixture must be classified as a mixture that causes specific target organ toxicity arising from a single exposure in accordance with section 8.8.1.
Hazardous Products Regulations — 8.8.4
Data available for use of bridging principles 8.8.4 If data are available to enable the characterization of the mixture as a mixture that causes specific target organ toxicity arising from a single exposure, in accordance with the bridging principles referred to in subsections 2.3(3) to (8), the mixture must be classified in one or more categories of this hazard class, based on the table to subsection 8.8.1(2), in accordance with those subsections.
Hazardous Products Regulations — 8.8.5
Data available for ingredients — Category 1, 2 or 3 8.8.5 (1) A mixture that contains one or more ingredients that are classified as a substance that causes specific target organ toxicity arising from a single exposure is classified as follows: (a) in the category “Specific Target Organ Toxicity — Single Exposure — Category 1”, if it contains at least one ingredient at a concentration equal to or greater than the concentration limit of 1.0% that is classified in the category “Specific Target Organ Toxicity — Single Exposure — Category 1”; (b) in the category “Specific Target Organ Toxicity — Single Exposure — Category 2”, if it contains at least one ingredient at a concentration equal to or greater than the concentration limit of 1.0% that is classified in the category “Specific Target Organ Toxicity — Single Exposure — Category 2”; (c) in the category “Specific Target Organ Toxicity — Single Exposure — Category 3”, if it contains at least one ingredient that is classified in the category “Specific Target Organ Toxicity — Single Exposure — Category 3” that is (i) at a concentration equal to or greater than the concentration at which the effect is elicited, if known, or (ii) at a concentration equal to or greater than the concentration limit of 20.0%; or (iii) [Repealed, SOR/2022-272, s. 55] (d) in the category “Specific Target Organ Toxicity — Single Exposure — Category 3”, if it contains at least two ingredients that are classified in that category which are present individually at a concentration of 1.0% or more and (i) such ingredients individually cause a transient narcotic effect, and the sum of their concentrations is equal to or greater than the concentration limit of 20.0%, or (ii) such ingredients individually cause transient respiratory tract irritation, and the sum of their concentrations is equal to or greater than the concentration limit of 20.0%. Data available for ingredients — Categories 1 and 3 or 2 and 3 (2) Despite subsection 2.2(3), a mixture that has been classified in accordance with paragraph (1)(a) or (b) and meets the criteria of paragraph (1)(c) is also classified in the category “Specific Target Organ Toxicity — Single Exposure — Category 3”. SOR/2022-272, s. 55
Hazardous Products Regulations — 8.9
Definitions 8.9 The following definitions apply in this Subpart. organ includes any biological system. ( organe ) specific target organ toxicity arising from repeated exposure means specific toxic effects on target organs that arise from repeated exposure to a mixture or substance, including all health effects liable to impair function of the body or any of its parts, whether reversible or irreversible, immediate or delayed, but excludes effects resulting from health hazards addressed by Subparts 1 to 7 and 10 of this Part. ( toxicité pour certains organes cibles à la suite d’expositions répétées )
Hazardous Products Regulations — Hazardous Products Regulations
specific target organ toxicity arising from repeated exposure means specific toxic effects on target organs that arise from repeated exposure to a mixture or substance, including all health effects liable to impair function of the body or any of its parts, whether reversible or irreversible, immediate or delayed, but excludes effects resulting from health hazards addressed by Subparts 1 to 7 and 10 of this Part. ( toxicité pour certains organes cibles à la suite d’expositions répétées )
Hazardous Products Regulations — 8.9.1
Categories 8.9.1 A substance that causes specific target organ toxicity arising from repeated exposure is classified in a category of this hazard class in accordance with the following table: TABLE Column 1 Column 2 Item Category Criteria 1 Specific Target Organ Toxicity — Repeated Exposure — Category 1 A substance that (a) according to human data, causes specific target organ toxicity arising from repeated exposure; or (b) according to animal data, causes specific target organ toxicity arising from repeated exposure at low exposure concentrations, within the concentration value ranges set out in Table 3.9.1 of the GHS 2 Specific Target Organ Toxicity — Repeated Exposure — Category 2 A substance that, according to animal data, causes specific target organ toxicity arising from repeated exposure at moderate exposure concentrations, within the concentration value ranges set out in Table 3.9.2 of the GHS
Hazardous Products Regulations — (a)
A substance that (a) according to human data, causes specific target organ toxicity arising from repeated exposure; or (b) according to animal data, causes specific target organ toxicity arising from repeated exposure at low exposure concentrations, within the concentration value ranges set out in Table 3.9.1 of the GHS
Hazardous Products Regulations — (a)
(a) according to human data, causes specific target organ toxicity arising from repeated exposure; or
Hazardous Products Regulations — (b)
(b) according to animal data, causes specific target organ toxicity arising from repeated exposure at low exposure concentrations, within the concentration value ranges set out in Table 3.9.1 of the GHS